non-small cell lung cancer (NSCLC)

Metastatic NSCLC patients to benefit from monotherapy drug option

Dr Bivas Biswas, Consultant, Medical Oncology at Tata Medical Center, Kolkata provides insight on improved progression-free survival (PFS) and overall…